Latest Breaking News On - Genomic based medicine - Page 1 : comparemela.com

Share this article Share this article ResearchAndMarkets.com s offering. This report highlights that the market is projected to reach $40.6 billion by 2030. The study also highlights that the market is set to witness a CAGR of 6.09% during the period 2020-2030. The market is driven by the need for the development of an advanced solution based on various technologies such as next-generation sequencing, in-situ hybridization, and polymerase chain reaction for cancer research in various applications such as diagnosis, prognosis, and treatment. The market is favored by the development of high-throughput, rapid, sensitive, and multi-parametric solutions for prognosis, diagnostics, and treatment. The gradual increase in the prevalence of cancer globally has furthered the solid tumor testing market.

United statesLaura woodRole of invitae corporation incRole of invivoscribe incRole of bio rad laboratories incInvitae corporationRole of quest diagnosticsRoche ltdInvivoscribe incCompany overviewOffice hours callLaboratory corporation of america holdingsResearch methodologyAsuragen incNeogenomics laboratories incRole of guardant health